These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 642513)

  • 21. Immunohistochemical study for the expression of Bcl-2 family proteins in Walker 256 carcinosarcoma cells under the influence of cytostatic drugs.
    Ovsjanko EV; Lushnikova EL; Larionov PM; Arkhipov SA; Nepomnyashchikh LM; Efremov AV; Ovsjanko YU
    Bull Exp Biol Med; 2009 Oct; 148(4):650-5. PubMed ID: 20396763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combined effect of intravenous hyperalimentation and chemotherapy on experimental meningioma].
    Yamada K; Ushio Y; Hayakawa T; Mogami H; Okada A; Hasegawa J
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1589-94. PubMed ID: 6820921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Disorders of blood rheology in Walker's carcinosarcoma-256 and in cyclophosphamide treatment of rats].
    Plotnikov MB; Maslov MIu; Aliev OI; Vasil'ev AS; Zueva EP; Krylova SG; Shilova NV
    Vopr Onkol; 2001; 47(3):335-7. PubMed ID: 11544834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experimental evaluation of tumor therapy with cytostatic agents deposited in the abdominal cavity in acetylcellulose].
    Chissov VI; Borisov VI; Rusakov IG; Shchitkov KG; Il'ina AI
    Eksp Onkol; 1987; 9(1):65-8. PubMed ID: 3816661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement by hydrazine sulfate of antitumor effectiveness of cytoxan, mitomycin C, methotrexate and bleomycin, in walker 256 carcinosarcoma in rats.
    Gold J
    Oncology; 1975; 31(1):44-53. PubMed ID: 51492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of induced tumour-resistance to cyclophosphamide by the in vitro short term test.
    Volm M; Mattern J; Wayss K
    Arch Gynakol; 1977 Nov; 223(4):249-57. PubMed ID: 579579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of remission with l-Asparaginase, cyclophosphamide, cytosine arabinoside, and prednisolone in adult patients with acute leukemia.
    Gahrton G; Engstedt L; Franzén S; Gullbring B; Holm G; Höglund S; Killander A; Killander D; Lockner D; Mellstedt H; Palmblad J; Reizenstein P; Skarberg KO; Swedberg B; Udén AM
    Cancer; 1974 Aug; 34(2):472-9. PubMed ID: 4527847
    [No Abstract]   [Full Text] [Related]  

  • 28. Proliferation of Walker 256 carcinosarcoma cells: effect of whole-body hyperthermia and antitumor agents.
    Lushnikova EL; Ovsyanko EV; Nepomnyashchikh LM; Efremov AV; Morozov DV
    Bull Exp Biol Med; 2011 Nov; 152(1):146-52. PubMed ID: 22803062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Systemic administration of cyclophosphamide in malignant bone tumors].
    Matsumori S; Kobayashi I; Watanabe E
    Saishin Igaku; 1971 Mar; 26(3):563-71. PubMed ID: 5278389
    [No Abstract]   [Full Text] [Related]  

  • 30. Enhancement of the cancer chemotherapeutic effect of the cell cycle phase specific agents methotrexate and cytosine arabinoside when given as a water-oil-water emulsion.
    Benoy CJ; Schneider R; Elson LA; Jones M
    Eur J Cancer (1965); 1974 Jan; 10(1):27-33. PubMed ID: 4435002
    [No Abstract]   [Full Text] [Related]  

  • 31. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat.
    Kooistra KL; Rodriguez M; Powis G
    Cancer Res; 1989 Feb; 49(4):977-82. PubMed ID: 2912564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of cyclophosphamide and 2,3,5-tris-ethyleniminobenzoquinone-(1,4) on tumor cells in diffusion chambers].
    Teichmann B
    Arzneimittelforschung; 1965 May; 15(5):532-4. PubMed ID: 5898339
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyclophosphamide (NSC-26271), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) (COAP) combination chemotherapy for acute leukemia in adults.
    Whitecar JP; Bodey GP; Freireich EJ; McCredie KB; Hart JS
    Cancer Chemother Rep; 1972 Aug; 56(4):543-50. PubMed ID: 5081596
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of N-acetylcysteine on the antitumor activity of cyclophosphamide against Walker-256 carcinosarcoma in rats.
    Harrison EF; Fuquay ME; Hunter HL
    Semin Oncol; 1983 Mar; 10(1 Suppl 1):25-8. PubMed ID: 6836324
    [No Abstract]   [Full Text] [Related]  

  • 35. Rapid control of chronic granulocytic leukaemia.
    Onwukeme KE; Lot TY
    Afr J Med Med Sci; 1993 Jun; 22(2):51-6. PubMed ID: 7839898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytosine arabinoside/cyclophosphamide pulses during continuation therapy for childhood acute lymphoblastic leukemia. Potential selective effect in T-cell leukemia.
    Lauer SJ; Pinkel D; Buchanan GR; Sartain P; Cornet JM; Krance R; Borella LD; Casper JT; Kun LE; Hoffman RG
    Cancer; 1987 Nov; 60(10):2366-71. PubMed ID: 3499211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potentiation of antitumor effect of cyclophosphamide and hydrazine sulfate by treatment with the antidiabetic agent, 1-phenylethylbiguanide (phenformin).
    Dilman VM; Anisimov VN
    Cancer Lett; 1979 Oct; 7(6):357-61. PubMed ID: 509414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of a case of childhood acute non-lymphocytic leukemia (ANLL) using high-dose cytosine arabinoside for intensification of early therapy].
    Imashuku S; Nakajima T; Morimoto S; Hibi S; Todo S; Morioka Y; Sugimoto T
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):527-30. PubMed ID: 3813580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of acute necrosis in Walker 256 tumors in rats.
    Orvoine RH; Seidman JM
    Cancer Res; 1977 Jan; 37(1):102-5. PubMed ID: 830398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Enhancement of the antitumor effect of cyclophosphane in an experiment].
    Chissov VI; Rusakov IG; Shchitkov KG; Igitov VI; Solodovnik VD
    Vopr Onkol; 1985; 31(12):80-6. PubMed ID: 4082511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.